Clinical Trials in Dallas

Showing 6461-6480 of 17,468 trials

A Trial to Evaluate the Effect of Food on LEO 152020

NCT04203836

A phase 1 trial in healthy people to evaluate the food effect on LEO 152020 in an open-label design using film-coated tablets

Healthy

JW Pharmaceutical12 participantsStarted Jan 2020

Dallas, Texas, United States • Leeds, United Kingdom

TERMINATEDPhase 3< 1 mile

A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

NCT04552899

This phase III study will evaluate the efficacy, safety and pharmacokinetics (PK) of recombinant human pentraxin-2 (rhPTX-2; PRM-151) zinpentraxin alfa, compared with placebo in participants with idiopathic pulmonary fibrosis (IPF).

Idiopathic Pulmonary Fibrosis

Hoffmann-La Roche665 participantsStarted Mar 2021

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +357 more locations

A Trial to Evaluate the Effect of Food on LEO 152020

A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

Find Trials by Condition in Dallas

Brain Oxygenation-II

Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke

A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD)

Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain Metastases

Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age

PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma

PRS-343 in HER2-Positive Solid Tumors

Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years

Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients

LYT-100 in Patients With BCRL

Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology